|Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study|
MJ Cummings, MR Baldwin, D Abrams, SD Jacobson, BJ Meyer, ...
The Lancet, 2020
|High incidence of hospital admissions with multidrug-resistant and extensively drug-resistant tuberculosis among South African health care workers|
MR O'Donnell, J Jarand, M Loveday, N Padayatchi, J Zelnick, L Werner, ...
Annals of internal medicine 153 (8), 516-522, 2010
|Evolution of extensively drug-resistant tuberculosis over four decades: whole genome sequencing and dating analysis of Mycobacterium tuberculosis isolates from KwaZulu-Natal|
KA Cohen, T Abeel, AM McGuire, CA Desjardins, V Munsamy, TP Shea, ...
PLoS Med 12 (9), e1001880, 2015
|Treatment correlates of successful outcomes in pulmonary multidrug-resistant tuberculosis: an individual patient data meta-analysis|
TCG for the Meta, N Ahmad, SD Ahuja, OW Akkerman, JWC Alffenaar, ...
The Lancet 392 (10150), 821-834, 2018
|Revisiting rates of reactivation tuberculosis: a population-based approach|
CR Horsburgh Jr, M O'Donnell, S Chamblee, JL Moreland, J Johnson, ...
American journal of respiratory and critical care medicine 182 (3), 420-425, 2010
|Linezolid vs glycopeptide antibiotics for the treatment of suspected methicillin-resistant Staphylococcus aureus nosocomial pneumonia: a meta-analysis of randomized controlled …|
AJ Walkey, MR O'Donnell, RS Wiener
Chest 139 (5), 1148-1155, 2011
|Genomic and functional analyses of Mycobacterium tuberculosis strains implicate ald in D-cycloserine resistance|
CA Desjardins, KA Cohen, V Munsamy, T Abeel, K Maharaj, BJ Walker, ...
Nature genetics 48 (5), 544-551, 2016
|Systematic review of clofazimine for the treatment of drug-resistant tuberculosis|
M Gopal, N Padayatchi, JZ Metcalfe, MR O'Donnell
The International journal of tuberculosis and lung disease 17 (8), 1001-1007, 2013
|Treatment outcomes for extensively drug-resistant tuberculosis and HIV co-infection|
MR O’Donnell, N Padayatchi, C Kvasnovsky, L Werner, I Master, ...
Emerging infectious diseases 19 (3), 416, 2013
|Improved early results for patients with extensively drug-resistant tuberculosis and HIV in South Africa|
MR O'Donnell, N Padayatchi, I Master, G Osburn, CR Horsburgh
The International journal of tuberculosis and lung disease 13 (7), 855-861, 2009
|Preferential adherence to antiretroviral therapy over tuberculosis treatment: a qualitative study of drug-resistant TB/HIV co-infected patients in South Africa|
A Daftary, N Padayatchi, M O'Donnell
Global public health 9 (9), 1107-1116, 2014
|ϕ2GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples|
P Jain, TE Hartman, N Eisenberg, MR O'Donnell, J Kriakov, K Govender, ...
Journal of clinical microbiology 50 (4), 1362-1369, 2012
|Extensively drug‐resistant tuberculosis (XDR‐TB) among health care workers in South Africa|
J Jarand, K Shean, M O’Donnell, M Loveday, C Kvasnovsky, ...
Tropical Medicine & International Health 15 (10), 1179-1184, 2010
|Famotidine use is associated with improved clinical outcomes in hospitalized COVID-19 patients: A propensity score matched retrospective cohort study|
DE Freedberg, J Conigliaro, TC Wang, KJ Tracey, MV Callahan, ...
|Malnutrition associated with unfavorable outcome and death among South African MDR-TB and HIV co-infected children|
RM Hicks, N Padayatchi, NS Shah, A Wolf, L Werner, VB Sunkari, ...
The International journal of tuberculosis and lung disease 18 (9), 1074-1083, 2014
|Re-inventing adherence: toward a patient-centered model of care for drug-resistant tuberculosis and HIV|
MR O'Donnell, A Daftary, M Frick, Y Hirsch-Moverman, KR Amico, ...
The International Journal of Tuberculosis and Lung Disease 20 (4), 430-434, 2016
|The impact of the HIV/AIDS epidemic on hospital nurses in KwaZulu Natal, South Africa: nurses' perspectives and implications for health policy|
J Zelnick, M O'Donnell
Journal of public health policy 26 (2), 163-185, 2005
|Adherence in the treatment of patients with extensively drug-resistant tuberculosis and HIV in South Africa: a prospective cohort study|
MR O’Donnell, A Wolf, L Werner, CR Horsburgh, N Padayatchi
Journal of acquired immune deficiency syndromes (1999) 67 (1), 22, 2014
|Clofazimine in the treatment of extensively drug-resistant tuberculosis with HIV coinfection in South Africa: a retrospective cohort study|
N Padayatchi, M Gopal, R Naidoo, L Werner, K Naidoo, I Master, ...
Journal of Antimicrobial Chemotherapy 69 (11), 3103-3107, 2014
|Health-care workers’ perspectives on workplace safety, infection control, and drug-resistant tuberculosis in a high-burden HIV setting|
JR Zelnick, A Gibbs, M Loveday, N Padayatchi, MR O'donnell
Journal of public health policy 34 (3), 388-402, 2013